Factors associated with high glucose variability in patients with type 1 diabetes

Factors associated with high glucose variability in patients with type 1 diabetes

BACKGROUND: High glucose variability (GV) is recognized as a risk factor for vascular diabetic complications and hypoglycemia. Factors affecting GV in patients with diabetes needed to be clarified.AIM: To determine the factors associated with high GV in adult patients with type 1 diabetes.MATERIALS...

Full description

Bibliographic Details
Main Authors:	V. V. Klimontov, Ju. F. Semenova, A. I. Korbut
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2022-10-01
Series:	Сахарный диабет
Subjects:	type 1 diabetes insulin therapy glucose variability continuous glucose monitoring continuous subcutaneous insulin infusion
Online Access:	https://www.dia-endojournals.ru/jour/article/view/12888

Similar Items

Evaluation of glycaemic profile variability as a basis for insulin therapy strategy in pregnant women with type 1 diabetes
by: Alena V. Tiselko, et al.
Published: (2019-12-01)

The 5th International Conference on Advanced Technologies Treatments for Diabetes (ATTD 2012),2012 February 8-11, Barcelona (Spain)
by: Yury Ivanovich Filippov, et al.
Published: (2012-03-01)

Telemedicine in the Time of the COVID-19 Pandemic: Results from the First Survey among Italian Pediatric Diabetes Centers
by: Gianluca Tornese, et al.
Published: (2021-06-01)

The Benefits and Limits of Technological Advances in Glucose Management Around Physical Activity in Patients Type 1 Diabetes
by: Sémah Tagougui, et al.
Published: (2019-01-01)

Continuous Subcutaneous Insulin Infusion in Children: A Pilot Study Validating a Protocol to Avoid Hypoglycemia at Initiation
by: Patricia Olivier, et al.
Published: (2017-04-01)

Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis
by: Guo Keyu, et al.
Published: (2022-08-01)

Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy
by: Flavia Urbano, et al.
Published: (2023-07-01)

Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis
by: Conway RB, et al.
Published: (2023-08-01)

Reference values of 24-hour, day-time and nocturnal glucose variability parameters in subjects with normal glucose tolerance
by: Ju. F. Semenova, et al.
Published: (2022-05-01)

Psychosocial aspects of the usage of modern technologies in diabetes mellitus
by: Oleg G. Motovilin, et al.
Published: (2019-08-01)

Increased glycemic variability in type 2 diabetes patients treated with insulin - a real-life clinical practice, continuous glucose monitoring (CGM) study
by: Crăciun Cristian-Ioan, et al.
Published: (2018-07-01)

Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)
by: Goran Petrovski, et al.
Published: (2022-03-01)

Availability and accessibility of diabetes-related technologies in IDF-MENA Region
by: Erum Ghafoor, et al.
Published: (2022-01-01)

The role of technology in the care of diabetes mellitus in pregnancy: an expert review
by: Sydney M. Thayer, MD, et al.
Published: (2023-08-01)

Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now?
by: Erika Pedone, et al.
Published: (2020-10-01)

Glycaemic control and novel technology management strategies in pregestational diabetes mellitus
by: Christine Newman, et al.
Published: (2023-01-01)

Characteristics of pregnancy complicated with type 1 and type 2 diabetes
by: Misaki Koyama, et al.
Published: (2023-09-01)

Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care
by: Guido Kramer, et al.
Published: (2021-07-01)

RT‐CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: Systemic review and meta‐analysis
by: Jimmy William, et al.
Published: (2022-03-01)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
by: Ekaterina Viktorovna Artemova, et al.
Published: (2012-09-01)

Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
by: Vadim Valer'evich Klimontov, et al.
Published: (2014-03-01)

The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy
by: Vadim V. Klimontov, et al.
Published: (2015-12-01)

Sex-Specific Associations Between Low Muscle Mass and Glucose Fluctuations in Patients With Type 2 Diabetes Mellitus
by: Xiulin Shi, et al.
Published: (2022-07-01)

Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation
by: Rob Riemsma, et al.
Published: (2016-02-01)

Use of flash glucose-sensing technology in patients with type 2 diabetes treated with liraglutide combined with CSII: a pilot study
by: Ming-yan Yao, et al.
Published: (2019-12-01)

A Systematic Review and Meta-Analysis of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections in Type-2 Diabetes
by: Vasiliki Chatziravdeli, et al.
Published: (2023-01-01)

Alterations in the Levels of Circulating and Endothelial Progenitor Cells Levels in Young Adults with Type 1 Diabetes: A 2-Year Follow-Up from the Observational METRO Study
by: Longo M, et al.
Published: (2020-03-01)

Efficacy and safety of SGLT2 inhibitors in individuals with type 1 diabetes under continuous subcutaneous insulin infusion: a real-world study
by: Silva Vania Benido, et al.
Published: (2023-01-01)

Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus
by: Takafumi Masuda, et al.
Published: (2022-09-01)

A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial
by: Simon Heller, et al.
Published: (2017-04-01)

Basal Insulin Reduces Glucose Variability and Hypoglycaemia Compared to Premixed Insulin in Type 2 Diabetes Patients: A Study Based on Continuous Glucose Monitoring Systems
by: Huiying Wang, et al.
Published: (2022-04-01)

Current Diabetes Technology: Striving for the Artificial Pancreas
by: Natalie Allen, et al.
Published: (2019-03-01)

Effect of the Chinese New Year Public Holiday on the Glycemic Control of T1DM With Intensive Insulin Therapy
by: Keyu Guo, et al.
Published: (2022-06-01)

Corrigendum: Effect of the Chinese New Year public holiday on the glycemic control of T1DM with intensive insulin therapy
by: Keyu Guo, et al.
Published: (2022-07-01)

Insulin pump therapy in type 1 diabetes mellitus: education effectiveness and quality of life
by: Lyudmila Ibragimovna Ibragimova, et al.
Published: (2012-03-01)

A Minimal Model Approach for Analyzing Continuous Glucose Monitoring in Type 2 Diabetes
by: Pranay Goel, et al.
Published: (2018-06-01)

Using the Novel Approach of an Artificial Pancreas to Manage Type 1 Diabetes Mellitus in Pregnancy
by: Yael Lefkovits, et al.
Published: (2019-06-01)

Menstrual Cycle, Glucose Control and Insulin Sensitivity in Type 1 Diabetes: A Systematic Review
by: Elena Gamarra, et al.
Published: (2023-02-01)

Editorial: Daily challenges around physical exercise, nutrition and medication in type 1 diabetes
by: Othmar Moser, et al.
Published: (2023-07-01)

Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections in Pediatric Type 1 Diabetes: A Meta‐Analysis and Prospective Cohort Study
by: Xu Wang, et al.
Published: (2021-03-01)